Administration of vellajadi churna for vataj arsh with speacial reference to external haemorroides

Randomized Open Controlled clinical study of vellajadi churn in vataj arsha with special reference to external Haemorroids.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/032606

Enrollment

Registered

2021-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K90-K95- Other diseases of the digestive system

Interventions

Intervention1: Tablet Anocare 500mg 2 tablet: 2 gm vellajadi churna with 4 gm guda 500mg tablet anocare 2 Intervention2: Vellajadi Churna: 2 gm vellajadi churna with 4 gm guda twice a day before meal

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Vataj Arsha selected on the basis of clinical featues

Exclusion criteria

Exclusion criteria: Anal polyp Anal Fissure

Design outcomes

Primary

Measure	Time frame
Randomized Open controlled clinical study of vellajadi churna in vataj arsha with speacial reference to extern haemorroidsTimepoint: 18 months	—

Secondary

Measure	Time frame
To study disease Arsha in deatails.To study the bheshaj effect of vellajadi churna in vataj arshaTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr AnuradhaAnandrao Chalke

Yashwant Ayurvedic college kodoli Kolhapur

drsrinivast@gmail.com9503147698

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026